Antarctic fungi offer new hope for Alzheimer’s drug discovery - Teoh Teow Chong and Mohammed Rizman Idid
Researchers from Universiti Malaya have discovered that fungi from Antarctica contain compounds that may help treat Alzheimer's disease. These fungi have evolved unique survival strategies that produce natural antioxidants capable of interacting with Alzheimer's-related proteins.
Why it matters
This discovery highlights the potential for extreme-environment biodiversity to provide breakthroughs in medical research and drug development.
AUGUST 17 — Antarctica is best known for its vast ice sheets and its role in regulating the Earth’s climate. Yet beyond its frozen landscape lies one of the world’s last great frontiers for scientific discovery. Researchers from Universiti Malaya have uncovered promising evidence that fungi from Antarctica may contribute to the development of future treatments for Alzheimer’s disease, demonstrating how Antarctic research can generate tangible benefits for human health and society.
The study focuses on Pseudogymnoascus , a group of fungi isolated from Antarctic ecosystems. Living in one of the harshest environments on Earth, these microorganisms have evolved remarkable survival strategies to withstand subzero temperatures, intense ultraviolet radiation, prolonged darkness and limited nutrient availability. These extraordinary adaptations have enabled them to produce unique natural compounds rarely found elsewhere, making Antarctica a valuable natural laboratory for discovering new medicines, biotechnology innovations and other solutions to global challenges.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in